209 related articles for article (PubMed ID: 15947259)
41. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.
Asahi M; Wang X; Mori T; Sumii T; Jung JC; Moskowitz MA; Fini ME; Lo EH
J Neurosci; 2001 Oct; 21(19):7724-32. PubMed ID: 11567062
[TBL] [Abstract][Full Text] [Related]
42. Over-expression of VEGF in marrow stromal cells promotes angiogenesis in rats with cerebral infarction via the synergistic effects of VEGF and Ang-2.
Lai T; Li M; Zheng L; Song Y; Xu X; Guo Y; Zhang Y; Zhang Z; Mei Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Oct; 32(5):724-731. PubMed ID: 23073804
[TBL] [Abstract][Full Text] [Related]
43. The roles of vascular endothelial growth factor and angiopoietin-2 in the regression of pregnancy pyogenic granuloma.
Yuan K; Lin MT
Oral Dis; 2004 May; 10(3):179-85. PubMed ID: 15089929
[TBL] [Abstract][Full Text] [Related]
44. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors.
Udani V; Santarelli J; Yung Y; Cheshier S; Andrews A; Kasad Z; Tse V
Neurol Res; 2005 Dec; 27(8):801-6. PubMed ID: 16354539
[TBL] [Abstract][Full Text] [Related]
45. Angiogenesis in the brain during development: the effects of vascular endothelial growth factor and angiopoietin-2 in an animal model.
Vates GE; Hashimoto T; Young WL; Lawton MT
J Neurosurg; 2005 Jul; 103(1):136-45. PubMed ID: 16121984
[TBL] [Abstract][Full Text] [Related]
46. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor.
Zhou YF; Stabile E; Walker J; Shou M; Baffour R; Yu Z; Rott D; Yancopoulos GD; Rudge JS; Epstein SE
J Am Coll Cardiol; 2004 Aug; 44(4):897-903. PubMed ID: 15312878
[TBL] [Abstract][Full Text] [Related]
47. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
[TBL] [Abstract][Full Text] [Related]
48. Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
Lee CZ; Xue Z; Zhu Y; Yang GY; Young WL
Stroke; 2007 Sep; 38(9):2563-8. PubMed ID: 17673717
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats.
Melgar-Lesmes P; Tugues S; Ros J; Fernández-Varo G; Morales-Ruiz M; Rodés J; Jiménez W
Gut; 2009 Feb; 58(2):285-92. PubMed ID: 18978178
[TBL] [Abstract][Full Text] [Related]
50. VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue.
Benest AV; Salmon AH; Wang W; Glover CP; Uney J; Harper SJ; Bates DO
Microcirculation; 2006 Sep; 13(6):423-37. PubMed ID: 16864410
[TBL] [Abstract][Full Text] [Related]
51. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
Tesan T; Gustavsson H; Welén K; Damber JE
BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
[TBL] [Abstract][Full Text] [Related]
53. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
[TBL] [Abstract][Full Text] [Related]
54. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.
Kitayama H; Maeshima Y; Takazawa Y; Yamamoto Y; Wu Y; Ichinose K; Hirokoshi K; Sugiyama H; Yamasaki Y; Makino H
Am J Hypertens; 2006 Jul; 19(7):718-27. PubMed ID: 16814127
[TBL] [Abstract][Full Text] [Related]
55. Roles of vascular endothelial growth factor, Angiopoietin 1, and Angiopoietin 2 in nasal polyp.
Park SK; Kim HI; Yang YI
Laryngoscope; 2009 Feb; 119(2):409-13. PubMed ID: 19160387
[TBL] [Abstract][Full Text] [Related]
56. The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
Chen ZB; Shen SQ; Ding YM; Wang WX; Tao JP; Liang LJ; Hu WJ
Med Oncol; 2009; 26(3):365-71. PubMed ID: 19082771
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
[TBL] [Abstract][Full Text] [Related]
58. The impact of early RPE cell junction loss on VEGF, Ang-2, and TIMP secretion in vitro.
Paterson C; Cannon J; Vargis E
Mol Vis; 2023; 29():87-101. PubMed ID: 37859808
[TBL] [Abstract][Full Text] [Related]
59. Nitric oxide in vascular endothelial growth factor-induced focal angiogenesis and matrix metalloproteinase-9 activity in the mouse brain.
Lee CZ; Xue Z; Hao Q; Yang GY; Young WL
Stroke; 2009 Aug; 40(8):2879-81. PubMed ID: 19498186
[TBL] [Abstract][Full Text] [Related]
60. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
